EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A novel signature constructed by cuproptosis-related RNA methylation regulators suggesting downregulation of YTHDC2 may induce cuproptosis resistance in colorectal cancer

Zhongkai Zhao, Zeyu Miao, Yuyang Hou, Yifan Zhong, Xiaorong Zhang, Xuedong Fang

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112691 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Zhongkai Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Colorectal Surgery, China-Japan Union Hospital of Jilin University, No. 126 Sendai Street, Changchun, Jilin, China. El…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Gene Expression Regulation, Neoplastic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: A newly identified type of cell death due to intracellular copper accumulation is known as cuproptosis and RNA methylation is a post-transcriptional modification mechanism, both of which perform vital roles in the immune microenvironment of colorectal cancer (CRC), but the link between the two needs more research. METHODS: TCGA database provided RNA-seq data and details clinically of CRC samples. Cuproptosis-related RNA methylation regulators (CRRMRs) were identified by correlation analysis. We screened 6 CRRMRs for prognostic model construction by employing LASSO-Cox regression analysis and calculated risk scores by CRRMRs (CuMS). GSE39582 and GSE38832 cohort were used as external validation sets. This research concentrated on the connection between the prognostic model and somatic mutation, anti-cancer drug sensitivity, immune infiltration, immune checkpoint expression. In addition, we investigated the differential expression of YTHDC2 in epithelial cell subpopulations by single-cell analysis with GSE166555, calculated cuproptosis scores and performed pathway enrichment. In vitro experiments were performed to explore the consequences of knockdown of YTHDC2 on CRC cell proliferation and migration, as well as changes in CRC cell viability in response to elesclomol after knockdown of YTHDC2. In vivo experiments, we constructed the cell line-derived xenograft model to further validate the results of the in vitro experiments. RESULTS: The prognosis of CRC can be predicted by CuMS, which GSE39582 and GSE38832 confirmed. Two CuMS groups showed different tumor mutation burden (TMB) and immune infiltration. CuMS was connected to emerging immune checkpoints CD47 and PVR, therefore, it can be clinically complementary to TMB and microsatellite instability (MSI) status. In single-cell analysis, a subpopulation of epithelial cells with high YTHDC2 expression had a high cuproptosis score. In vitro experiments, knocking down YTHDC2 promoted cell proliferation and migration in CRC, and weaken the inhibitory effect of elesclomol and elesclomol-Cu on cell viability, which in vivo experiments validated. CONCLUSION: We developed a prognostic model constructed by 6 CRRMRs to assess overall survival and immune microenvironment of CRC patients. YTHDC2 might regulate cuproptosis in multiple ways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsGene Expression Regulation, NeoplasticHumansAnimalsMiceDown-RegulationCell ProliferationDrug Resistance, NeoplasmCell Line, TumorTumor MicroenvironmentPrognosisMethylationCell MovementMice, NudeFemaleMaleRNA MethylationRNA Helicases

Stichwörter der Autor:innen

Colorectal cancerCuproptosisImmune microenvironmentRNA methylation regulatorsYTHDC2

Substanzen

YTHDC2 protein, humanRNA Helicases

Autor:innen und Institutionen

  • Department of Gastrointestinal Colorectal Surgery, China-Japan Union Hospital of Jilin University, No. 126 Sendai Street, Changchun, Jilin, China. Electronic address: zkzhao21@mails.jlu.edu.cn.
  • Department of Pathogenobiology, College of Basic Medical Sciences, Jilin University, No. 126 Xinmin Street, Changchun, Jilin, China. Electronic address: miaozy20@mails.jlu.edu.cn.
  • Department of Immunology, College of Basic Medical Sciences, Jilin University, No. 126 Xinmin Street, Changchun, Jilin, China. Electronic address: houyy19@mails.jlu.edu.cn.
  • Department of Pathogenobiology, College of Basic Medical Sciences, Jilin University, No. 126 Xinmin Street, Changchun, Jilin, China. Electronic address: zhongyf21@mails.jlu.edu.cn.
  • Department of Pathogenobiology, College of Basic Medical Sciences, Jilin University, No. 126 Xinmin Street, Changchun, Jilin, China. Electronic address: xiaorong22@mails.jlu.edu.cn.
  • Department of Gastrointestinal Colorectal Surgery, China-Japan Union Hospital of Jilin University, No. 126 Sendai Street, Changchun, Jilin, China. Electronic address: fangxd@jlu.edu.cn.

Zitieren

APA

Zhao, Z., Miao, Z., Hou, Y., Zhong, Y., Zhang, X., & Fang, X. (2024). A novel signature constructed by cuproptosis-related RNA methylation regulators suggesting downregulation of YTHDC2 may induce cuproptosis resistance in colorectal cancer. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112691

Vancouver

Zhao Z, Miao Z, Hou Y, Zhong Y, Zhang X, Fang X. A novel signature constructed by cuproptosis-related RNA methylation regulators suggesting downregulation of YTHDC2 may induce cuproptosis resistance in colorectal cancer. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112691

BibTeX
@article{Zhao2024,
  author = {Zhao, Zhongkai and Miao, Zeyu and Hou, Yuyang and Zhong, Yifan and Zhang, Xiaorong and Fang, Xuedong},
  title = {A novel signature constructed by cuproptosis-related RNA methylation regulators suggesting downregulation of YTHDC2 may induce cuproptosis resistance in colorectal cancer},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112691}
}
Kostenlos starten →